1.1 	A bill for an act
1.2 	relating to public safety; adding synthetic marijuana to the list of Schedule I 
1.3 	controlled substances; prescribing criminal penalties;amending Minnesota 
1.4 	Statutes 2010, section 152.02, subdivision 2.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. Minnesota Statutes 2010, section 152.02, subdivision 2, is amended to read:
1.7 		Subd. 2.Schedule I. The following items are listed in Schedule I:
1.8 	(1) Any of the following substances, including their isomers, esters, ethers, salts, and 
1.9 	salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of 
1.10 	such isomers, esters, ethers and salts is possible within the specific chemical designation: 
1.11 	Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alphamethadol; 
1.12 	Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; 
1.13 	Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; 
1.14 	Dimenoxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; 
1.15 	Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; 
1.16 	Ketobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; 
1.17 	Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; 
1.18 	Phenomorphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; 
1.19 	Trimeperidine.
1.20 	(2) Any of the following opium derivatives, their salts, isomers and salts of 
1.21 	isomers, unless specifically excepted, whenever the existence of such salts, isomers 
1.22 	and salts of isomers is possible within the specific chemical designation: Acetorphine; 
1.23 	Acetyldihydrocodeine; Acetylcodone; Benzylmorphine; Codeine methylbromide; 
1.24 	Codeine-N-Oxide; Cyprenorphine; Desomorphine; Dihydromorphine; Etorphine; Heroin; 
2.1 	Hydromorphinol; Methyldesorphine; Methylhydromorphine; Morphine methylbromide; 
2.2 	Morphine methylsulfonate; Morphine-N-Oxide; Myrophine; Nicocodeine; Nicomorphine; 
2.3 	Normorphine; Pholcodine; Thebacon.
2.4 	(3) Any material, compound, mixture or preparation which contains any quantity of 
2.5 	the following hallucinogenic substances, their salts, isomers and salts of isomers, unless 
2.6 	specifically excepted, whenever the existence of such salts, isomers, and salts of isomers 
2.7 	is possible within the specific chemical designation: 3,4-methylenedioxy amphetamine; 
2.8 	3,4-methylenedioxymethamphetamine; 4-bromo-2,5-dimethoxyamphetamine; 
2.9 	2,5-dimethoxyamphetamine; 4-methoxyamphetamine; 5-methoxy-3, 4-methylenedioxy 
2.10 	amphetamine; Bufotenine; Diethyltryptamine; Dimethyltryptamine; 3,4,5-trimethoxy 
2.11 	amphetamine; 4-methyl-2, 5-dimethoxyamphetamine; Ibogaine; Lysergic acid 
2.12 	diethylamide; marijuana; Mescaline; N-ethyl-3-piperidyl benzilate; N-methyl-3-piperidyl 
2.13 	benzilate; Psilocybin; Psilocyn; Tetrahydrocannabinols; 1-(1-(2-thienyl) cyclohexyl) 
2.14 	piperidine; n-ethyl-1-phenyl-cyclohexylamine; 1-(1-phenylcyclohexyl) pyrrolidine.
2.15 	(4) Peyote, providing the listing of peyote as a controlled substance in Schedule I 
2.16 	does not apply to the nondrug use of peyote in bona fide religious ceremonies of the 
2.17 	American Indian Church, and members of the American Indian Church are exempt 
2.18 	from registration. Any person who manufactures peyote for or distributes peyote to the 
2.19 	American Indian Church, however, is required to obtain federal registration annually and 
2.20 	to comply with all other requirements of law.
2.21 	(5) Unless specifically excepted or unless listed in another schedule, any material 
2.22 	compound, mixture, or preparation which contains any quantity of the following 
2.23 	substances having a depressant effect on the central nervous system, including its salts, 
2.24 	isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of 
2.25 	isomers is possible within the specific chemical designation:
2.26 	Mecloqualone;
2.27 	Flunitrazepam.
2.28 	(6) Unless specifically excepted or unless listed in another schedule, any material 
2.29 	compound, mixture, or preparation which contains any quantity of the following 
2.30 	substances having a stimulant effect on the central nervous system, including its salts, 
2.31 	isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of 
2.32 	isomers is possible within the specific chemical designation:
2.33 	Cathinone;
2.34 	Methcathinone.
2.35 	(7) Unless specifically excepted or unless listed in another schedule, any natural 
2.36 	or synthetic material, compound, mixture, or preparation that contains any quantity of 
3.1 	a substance that is a cannabinoid receptor agonist, including, but not limited to, the 
3.2 	following substances and their analogs, including homologues; isomers, whether optical, 
3.3 	positional, or geometric; esters; ethers; salts; and salts of isomers, esters, and ethers, 
3.4 	whenever the existence of the isomers, esters, ethers, or salts is possible within the specific 
3.5 	chemical designation:
3.6 	1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH-007), 
3.7 	(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone (JWH-015), 
3.8 	1-Pentyl-3-(1-naphthoyl)indole (JWH-018), 1-hexyl-3-(naphthalen-1-oyl)indole 
3.9 	(JWH-019), 1-Butyl-3-(1-naphthoyl)indole (JWH-073), 
3.10 	4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-081), 
3.11 	4-methoxynaphthalen-1-yl-(1-pentyl-2-methylindol-3-yl)methanone 
3.12 	(JWH-098), (1-(2-morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone 
3.13 	(JWH-200), 7-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone 
3.14 	(JWH-164), 2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-203), 
3.15 	4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-210), 
3.16 	2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-250), 
3.17 	1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398), (6aR,10aR)- 
3.18 	9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
3.19 	tetrahydrobenzo[c]chromen-1-ol (HU-210), (dexanabinol, (6aS,10aS)-9- 
3.20 	(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
3.21 	tetrahydrobenzo[c]chromen-1-ol) (HU-211), (R)-(+)-[2,3-Dihydro-5-methyl-3- 
3.22 	(4-morpholinylmethyl)pyrrolo[1,2,3-de)-1,4-benzoxazin-6-yl]-1-napthalenylmethanone 
3.23 	(WIN-55/212-2), 2-[(1R,3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl)phenol 
3.24 	(CP47,497), dimethylheptylpyran.

3.25 	EFFECTIVE DATE. This section is effective June 1, 2011, and applies to crimes 
3.26 	committed on or after that date.